Annual General Meeting results

RNS Number : 3733E

The MedicX Fund Limited

08 February 2018

 

Press Release

For immediate release                                                                                    

8 February 2018

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Annual General Meeting results

The Board of MedicX Fund Limited is pleased to announce that at the Annual General Meeting of its Shareholders held earlier today, each of the resolutions was duly proposed and passed by the appropriate majority. The details of the number of votes recorded in respect of each resolution was as follows:

The following resolutions were passed as ordinary resolutions:

Resolution	In favour	% In favour	Against	% Against	Votes withheld
1.  To reappoint KPMG LLP as auditors	182,400,582	99.99	12,034	0.01	15,750
2.  To authorise the Directors to determine the auditors' remuneration	182,428,366	100.00	-	-	-
3.  To approve the Annual Report and Financial Statements	182,384,573	99.98	43,792	0.02	-
4.  To approve the dividend policy	182,418,366	99.99	10,000	0.01	-
5.  To approve the directors' remuneration report	181,246,005	99.96	66,429	0.04	562
6.  To re-appoint John Hearle as director	182,316,619	99.95	93,963	0.05	17,784
7.  To re-appoint Stephen Le Page as director	181,181,854	99.94	113,358	0.06	17,784
8.  To appoint Helen Mahy as director	182,318,653	99.95	93,963	0.05	15,750
9.  To appoint Laure Duhot as director	181,195,888	99.94	101,358	0.06	15,750

The following resolutions were passed as special resolutions:

Resolution	In favour	% In favour	Against	% Against	Votes withheld
10.  Renewal of directors' authority to issue shares	182,393,497	99.99	22,869	0.01	12,000
11.  To authorise the Company to make market acquisitions of its ordinary shares (not exceeding 14.99 per cent. of its issued share capital, excluding treasury shares).	182,357,187	99.96	71,179	0.04	-
12.  (That subject to resolution 10) to authorise the directors to issue ordinary shares in the Company on a non pre-emptive basis	182,402,655	99.99	9,000	0.01	16,711

Notes:

·          A vote "withheld" is not a vote in law and is not calculated in the proportion of the votes "in favour" or "against" the resolution.

·          The total number of voting rights at the proxy deadline was 428,833,331.

For further information please contact:

Octopus Healthcare Adviser Ltd                                                    [phone]

Octopus Healthcare Group                                                           [phone]

Mike Adams, Chief Executive Officer

Canaccord Genuity

Andrew Zychowski/Helen Goldsmith                                             [phone]

Buchanan                                                                                  [phone]

Charles Ryland/Vicky Hayns

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", "MedicX Fund", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, listed on the London Stock Exchange, with a portfolio comprising 153 properties.

The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is part of the Octopus Healthcare group. Octopus Healthcare invests in and develops properties as well as creating partnerships to deliver innovative healthcare buildings to improve the health, wealth and wellbeing of the UK. It currently manages over £1.2 billion of healthcare investments across a number of platforms, with a focus on five core areas: GP surgeries, care homes, special education schools, retirement housing and private hospitals. Octopus Healthcare is part of the Octopus group, a fast-growing UK fund management business with leading positions in several specialist sectors including healthcare property, energy, property finance and smaller company investing. Octopus manages £7 billion of funds for more than 50,000 retail and institutional investors as well as supplying energy to more than 100,000 customers

Octopus Healthcare Adviser Ltd is authorised and regulated by the Financial Conduct Authority.

The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

The Company's Legal Entity Identifier is 2138008POF35FTNFCB25.

 

END

 

 

RAGEAKAPELSPEFF